van Oijen MGH - Search Results

1

Phase II Feasibility and Biomarker Study of Neoadjuvant Trastuzumab and Pertuzumab With Chemoradiotherapy for Resectable Human Epidermal Growth Factor Receptor 2-Positive Esophageal Adenocarcinoma: TRAP Study.

Stroes CI, Schokker S, Creemers A, Molenaar RJ, Hulshof MCCM, van der Woude SO, Bennink RJ, Mathôt RAA, Krishnadath KK, Punt CJA, Verhoeven RHA, van Oijen MGH, Creemers GJ, Nieuwenhuijzen GAP, van der Sangen MJC, Beerepoot LV, Heisterkamp J, Los M, Slingerland M, Cats A, Hospers GAP, Bijlsma MF, van Berge Henegouwen MI, Meijer SL, van Laarhoven HWM. Stroes CI, et al. Among authors: van oijen mgh, van der sangen mjc, van laarhoven hwm, van berge henegouwen mi, van der woude so. J Clin Oncol. 2020 Feb 10;38(5):462-471. doi: 10.1200/JCO.19.01814. Epub 2019 Dec 6. J Clin Oncol. 2020. PMID: 31809243 Free PMC article. Clinical Trial.

2

The effect of socioeconomic status on staging and treatment decisions in esophageal cancer.

Bus P, Aarts MJ, Lemmens VE, van Oijen MG, Creemers GJ, Nieuwenhuijzen GA, van Baal JW, Siersema PD. Bus P, et al. J Clin Gastroenterol. 2012 Nov-Dec;46(10):833-9. doi: 10.1097/MCG.0b013e31824e8ff8. J Clin Gastroenterol. 2012. PMID: 22460163

3

Combination of biodegradable stent placement and single-dose brachytherapy is associated with an unacceptably high complication rate in the treatment of dysphagia from esophageal cancer.

Hirdes MM, van Hooft JE, Wijrdeman HK, Hulshof MC, Fockens P, Reerink O, van Oijen MG, van der Tweel I, Vleggaar FP, Siersema PD. Hirdes MM, et al. Gastrointest Endosc. 2012 Aug;76(2):267-74. doi: 10.1016/j.gie.2012.04.442. Epub 2012 Jun 12. Gastrointest Endosc. 2012. PMID: 22695208 Clinical Trial.

4

Prognostic factors for medium- and long-term survival of esophageal cancer patients in the Netherlands.

Bus P, Lemmens VE, van Oijen MG, Creemers GJ, Nieuwenhuijzen GA, van Baal JW, Siersema PD. Bus P, et al. J Surg Oncol. 2014 Apr;109(5):465-71. doi: 10.1002/jso.23513. J Surg Oncol. 2014. PMID: 24783268

5

Burden of spousal caregivers of stage II and III esophageal cancer survivors 3 years after treatment with curative intent.

Haj Mohammad N, Walter AW, van Oijen MG, Hulshof MC, Bergman JJ, Anderegg MC, van Berge Henegouwen MI, Henselmans I, Sprangers MA, van Laarhoven HW. Haj Mohammad N, et al. Support Care Cancer. 2015 Dec;23(12):3589-98. doi: 10.1007/s00520-015-2727-4. Epub 2015 Apr 18. Support Care Cancer. 2015. PMID: 25894882 Free PMC article.

6

Optimal first-line chemotherapeutic treatment in patients with locally advanced or metastatic esophagogastric carcinoma: triplet versus doublet chemotherapy: a systematic literature review and meta-analysis.

Mohammad NH, ter Veer E, Ngai L, Mali R, van Oijen MG, van Laarhoven HW. Mohammad NH, et al. Cancer Metastasis Rev. 2015 Sep;34(3):429-41. doi: 10.1007/s10555-015-9576-y. Cancer Metastasis Rev. 2015. PMID: 26267802 Free PMC article. Review.

7

Metformin Use During Treatment of Potentially Curable Esophageal Cancer Patients is not Associated with Better Outcomes.

Spierings LE, Lagarde SM, van Oijen MG, Gisbertz SS, Wilmink JW, Hulshof MC, Meijer SL, Anderegg MC, van Berge Henegouwen MI, van Laarhoven HW. Spierings LE, et al. Ann Surg Oncol. 2015 Dec;22 Suppl 3:S766-71. doi: 10.1245/s10434-015-4850-3. Epub 2015 Sep 8. Ann Surg Oncol. 2015. PMID: 26350367

8

Timing of adjuvant chemotherapy and its relation to survival among patients with stage III colon cancer.

Bos AC, van Erning FN, van Gestel YR, Creemers GJ, Punt CJ, van Oijen MG, Lemmens VE. Bos AC, et al. Eur J Cancer. 2015 Nov;51(17):2553-61. doi: 10.1016/j.ejca.2015.08.016. Epub 2015 Sep 7. Eur J Cancer. 2015. PMID: 26360411

9

ABC-Transporter Expression Does Not Correlate with Response to Irinotecan in Patients with Metastatic Colorectal Cancer.

Trumpi K, Emmink BL, Prins AM, van Oijen MG, van Diest PJ, Punt CJ, Koopman M, Kranenburg O, Rinkes IH. Trumpi K, et al. J Cancer. 2015 Sep 3;6(11):1079-86. doi: 10.7150/jca.12606. eCollection 2015. J Cancer. 2015. PMID: 26516354 Free PMC article.

10

The efficacy and safety of S-1-based regimens in the first-line treatment of advanced gastric cancer: a systematic review and meta-analysis.

Ter Veer E, Mohammad NH, Lodder P, Ngai LL, Samaan M, van Oijen MG, van Laarhoven HW. Ter Veer E, et al. Gastric Cancer. 2016 Jul;19(3):696-712. doi: 10.1007/s10120-015-0587-8. Epub 2016 Jan 11. Gastric Cancer. 2016. PMID: 26754295 Free PMC article. Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

261 results

Search Page